Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2000
04/05/2000EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
04/05/2000EP0990038A1 New human lysophospholipase
04/05/2000EP0990031A2 Tumor necrosis factor receptor 5
04/05/2000EP0989999A1 Antitumoral composition based on immunogenic polypeptide with modified cell location
04/05/2000EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
04/05/2000EP0989984A1 Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
04/05/2000EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists
04/05/2000EP0989861A1 Immunogenic compositions for induction of anti-tumor immunity
04/05/2000EP0989858A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same
04/05/2000EP0989851A1 Self-emulsifying formulation for acidic lipophilic compounds
04/05/2000CN1249749A Phthalazinones
04/05/2000CN1249748A Small molecules useful in treatment of inflamatory disease
04/05/2000CN1249690A Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
04/05/2000CN1051089C Fruit polyphenol, process for production thereof, and use thereof
04/05/2000CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof
04/05/2000CN1051083C Novel substd. puriny derivs. with immunomodulating activity
04/04/2000US6046340 Imidazole containing pseudodipeptide product and compositions containing the same
04/04/2000US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
04/04/2000US6046212 Antiallergic agents
04/04/2000US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors
04/04/2000US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae
04/04/2000US6045802 Antitumor agents treating cancer
04/04/2000US6045796 Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease
04/04/2000US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene
04/04/2000CA2204739C Macrocyclic lactone compounds and their production process
04/04/2000CA2173878C Polynucleotide for treating systemic lupus erythematosus
04/04/2000CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins
04/04/2000CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
03/2000
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE)
03/30/2000WO2000017361A2 Interferon-epsilon
03/30/2000WO2000017358A2 Human chaperone proteins
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017195A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000017175A1 INHIBITORS OF p38
03/30/2000WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017161A1 Cyclic ester or amide derivatives
03/30/2000WO2000016804A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN
03/30/2000WO2000016801A1 Methods of downmodulating the immune response to therapeutic proteins
03/30/2000WO2000016796A1 Chemokine receptor antagonist and cyclosporin in combined therapy
03/30/2000WO2000016793A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000WO2000016792A1 Isolation of nutrient-rich carotenoids and their formulations
03/30/2000WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/30/2000WO2000016760A2 New use of prostaglandin e2 antagonists
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000WO2000004016A3 Polymorph of ritonavir
03/30/2000WO2000002913B1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
03/30/2000WO2000000609A3 Molecules associated with apoptosis
03/30/2000WO2000000182A3 Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1999064593A3 Cell cycle regulation proteins
03/30/2000WO1999049892A3 Use of active p40 conjugates for nasal delivery
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000DE19831873A1 Process for therapeutic immuno-modulation comprises the use of cells with immuno-modulatory activity in an extra-corporeal circulation
03/30/2000CA2354037A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344390A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2344370A1 Chemokine receptor antagonist and cyclosporin in combined therapy
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae
03/30/2000CA2343916A1 Methods of downmodulating the immune response to therapeutic proteins
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343052A1 Methods of treating ige-associated disorders and compositions for use therein
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2341036A1 Cyclic ester or amide derivatives
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0989121A1 Substituted benzamides and their use as immunomodulators
03/29/2000EP0988862A2 Formulation for use in immunisation
03/29/2000EP0988381A1 T-cell receptor beta-like protein
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988054A1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
03/29/2000EP0988053A1 Purified saponins as oral adjuvants
03/29/2000EP0988050A1 UTILIZATION OF $i(WOLINELLA SUCCINOGENES) ASPARAGINASE TO TREAT DISEASES ASSOCIATED WITH ASPARAGINE DEPENDENCE
03/29/2000EP0988047A1 Soluble ctla4 mutant molecules and uses thereof
03/29/2000EP0988046A1 Oil-free pharmaceutical compositions containing cyclosporin a
03/29/2000EP0988044A1 Centipeda plant extract
03/29/2000EP0988042A1 A combination therapy for hiv infections
03/29/2000EP0868420B1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity
03/29/2000EP0734389B1 Rapamycin derivatives useful as immunosuppressants
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
1 ... 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 ... 1172